Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Reich

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Cancer Treatment Reports|May 1, 1979
American experience with carminomycinL H Baker, D H Kessel, R L Comis, et al.
Gynecologic Oncology|January 1, 1985
Clinical pharmacology of intraperitoneal cisplatinJ A Lopez, J G Krikorian, S D Reich, et al.
Investigational New Drugs|January 1, 1983
Activity of two phase I drugs N-methylformamide (NSC-3051) and Echinomycin (NSC-526417) against fresh surgical explants of human tumors in the 6-day subrenal capsule (SRC) assayW R Cobb, A E Bogden, S D Reich, et al.
Cancer Treatment Reports|February 1, 1983
Activity of two phase I drugs, homoharringtonine and tricyclic nucleotide, against surgical explants of human tumors in the 6-day subrenal capsule assayW R Cobb, A E Bogden, S D Reich, et al.
European Journal of Cancer|December 1, 1980
Carminomycin (NSC-180024): a phase I studyR Abele, M Rozencweig, J J Body, et al.
Cancer Research|July 1, 1983
Murine metabolism and disposition of iron:adriamycin complexesM J Egorin, R E Clawson, L A Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1987
A randomized phase I/II study of continuous versus intermittent intravenous interferon gamma in patients with metastatic melanomaM S Ernstoff, T Trautman, C A Davis, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
Pharmacokinetics of carminomycin in dogs and humans. Preliminary reportS D Reich, S E Fandrich, T T Finkelstein, et al.
Cancer|December 15, 1983
Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapyT W Griffin, A E Bogden, S D Reich, et al.
Investigational New Drugs|January 1, 1986
Recombinant gamma interferon in advanced breast cancer: a phase II trialH B Muss, M Caponera, P J Zekan, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Cancer Treatment Reports|May 1, 1979
American experience with carminomycinL H Baker, D H Kessel, R L Comis, et al.
Gynecologic Oncology|January 1, 1985
Clinical pharmacology of intraperitoneal cisplatinJ A Lopez, J G Krikorian, S D Reich, et al.
Investigational New Drugs|January 1, 1983
Activity of two phase I drugs N-methylformamide (NSC-3051) and Echinomycin (NSC-526417) against fresh surgical explants of human tumors in the 6-day subrenal capsule (SRC) assayW R Cobb, A E Bogden, S D Reich, et al.
Cancer Treatment Reports|February 1, 1983
Activity of two phase I drugs, homoharringtonine and tricyclic nucleotide, against surgical explants of human tumors in the 6-day subrenal capsule assayW R Cobb, A E Bogden, S D Reich, et al.
European Journal of Cancer|December 1, 1980
Carminomycin (NSC-180024): a phase I studyR Abele, M Rozencweig, J J Body, et al.
Cancer Research|July 1, 1983
Murine metabolism and disposition of iron:adriamycin complexesM J Egorin, R E Clawson, L A Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1987
A randomized phase I/II study of continuous versus intermittent intravenous interferon gamma in patients with metastatic melanomaM S Ernstoff, T Trautman, C A Davis, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
Pharmacokinetics of carminomycin in dogs and humans. Preliminary reportS D Reich, S E Fandrich, T T Finkelstein, et al.
Cancer|December 15, 1983
Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapyT W Griffin, A E Bogden, S D Reich, et al.
Investigational New Drugs|January 1, 1986
Recombinant gamma interferon in advanced breast cancer: a phase II trialH B Muss, M Caponera, P J Zekan, et al.
Pageof 6